A splashy headline in The Washington Post caught my attention: “Breast cancer death rate dropped 58 percent over 44 years in U.S.” A Stanford Medicine news story reports that this victorious conclusion is based on “a new multicenter study led by Stanford Medicine clinicians and biomedical data scientists.” Using observational data, clinical trial data, and simulation modeling, the researchers
Which study is right? Investigating the impact of screening on breast cancer mortality originally appeared in KevinMD.com.
